Fresenius Medical Care announced a EUR 312 million investment to increase its ownership stake in Interwell Health (IWH), its Value-Based Care (VBC) asset. This transaction, finalized in early September, accelerates the timeline originally set during the merger of Cricket Health, Interwell Health, and Fresenius Health Partners in August 2022.
This increased investment enables Fresenius Medical Care to leverage its full scale and resources to support its VBC ambitions, aiming for streamlined decision-making and enhanced ability to deliver high-quality kidney care at lower cost. Interwell Health generated EUR 1,035 million in revenue for the first six months of the year, experiencing 23.5% growth.
Additionally, Tommy P. O'Connor has been appointed Chief Executive Officer of Interwell Health and business segment leader of VBC, effective October 1, 2025. Mr. O'Connor brings extensive healthcare leadership experience and will report to CEO Helen Giza, succeeding Robert Sepucha.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.